Topical versus oral carbonic anhydrase inhibitor therapy for pediatric glaucoma

Journal of AAPOS

Volumn 2, Issue 1, 1998, Pages 43-47

  Portellos, Maria ^a   Buckley, Edward G ^a   Freedman, Sharon F ^a  

^a DUKE UNIVERSITY EYE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE; CARBONATE DEHYDRATASE INHIBITOR; DORZOLAMIDE; SULFONAMIDE; THIOPHENE DERIVATIVE;

ARTICLE; CHILD; CLINICAL TRIAL; COMPARATIVE STUDY; CROSSOVER PROCEDURE; DRUG EFFECT; FEMALE; GLAUCOMA; HUMAN; INTRAOCULAR PRESSURE; MALE; ORAL DRUG ADMINISTRATION; PRESCHOOL CHILD; TOPICAL DRUG ADMINISTRATION;

ACETAZOLAMIDE; ADMINISTRATION, ORAL; ADMINISTRATION, TOPICAL; CARBONIC ANHYDRASE INHIBITORS; CHILD; CHILD, PRESCHOOL; CROSS-OVER STUDIES; FEMALE; GLAUCOMA; HUMANS; INTRAOCULAR PRESSURE; MALE; SULFONAMIDES; THIOPHENES;

EID: 0031988150     PISSN: 10918531     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1091-8531(98)90109-4     Document Type: Article

References (21)

1. Shrader CE, Thomas JV, Simmons RJ. Relationship of patient age and tolerance to carbonic anhydrase inhibitors. Am J Ophthalmol 1983;96:730-3.
2. Maren TH, Haywood JR, Chapman SK, Zimmerman TZ. The pharmacology of methazolamide in relation to the treatment of glaucoma. Invest Ophthalmol 1977;16:730-42.
3. Strahlman ER, Tipping MS, Vogel R. A six-week dose-response study of the ocular hypotensive effect of dorzolamide with a one-year extension. Am J Ophthalmol 1996;122:183-94.
4. Strahlman E, Tipping R, Vogel R, International Dorzolamide Study Group. A double-masked, randomized 1-year study comparing dorzolamide, timolol, and betaxolol. Arch Ophthalmol 1995;113:1009-16.
5. Strahlman ER, Deasy D, Panebianco D, Timolol/Dorzolamide Combination Study Group. A two-week pilot activity study of a fixed combination of timolol and dorzolamide hydrochloride [abstract]. Invest Ophthalmol Vis Sci 1993;34(suppl):1148.
6. Maus TL, Larsson L, McLaren JW, Brubaker RF. Comparison of dorzolamide and acetazolamide as suppressors of aqueous humor flow in humans. Arch Ophthalmol 1997;115:45-9.
7. Friedland BR, Mallonee J, Anderson DR. Short-term dose-response characteristics of acetazolamide in man. Arch Ophthalmol 1977;95:1809-12.
8. Becker B. Decrease in intraocular pressure in man by a carbonic anhydrase inhibitor, Diamox. Am J Ophthalmol 1954;37:13-5.
9. Alm A, Berggren L, Hartvig P, Roosdorp M. Monitoring acetazolamide treatment. Acta Ophthalmol (Copenh) 1982;60:24-33.
10. Berson FG, Epstein DL. Separate and combined effects of timolol maleate and acetazolamide in open-angle glaucoma. Am J Ophthalmol 1981;92:788-91.
11. Kass MA, Korey M, Gordon M, Becker B. Timolol and acetazolamide: a study of concurrent administration. Arch Ophthalmol 1982;100:941-2.
12. Nardin G, Lewis R, Lippa EA, Keates E, Coleman A, Clineschmidt C, et al. Activity of the topical CAI MK-507 bid when added to timolol bid [abstract]. Invest Ophthalmol Vis Sci 1991;32(suppl):989.
13. Strahlman ER, Vogel R, Tipping R, Clineschmidt CM, Dorzolamide Additivity Study Group. The use of dorzolamide and pilocarpine as adjunctive therapy to timolol in patients with elevated intraocular pressure. Ophthalmology 1996;103:1283-93.
14. Haas J. Principles and problems of therapy in congenital glaucoma. Invest Ophthalmol 1968;7:140-6.
15. Havener WH. Ocular pharmacology. 4th edition. St. Louis: CV Mosby; 1978.
16. Maren TH. The development of topical carbonic anhydrase inhibitors. J Glaucoma 1995;4:49-62.
17. Maren TH. A comparison between topical and oral sulfonamides in treatment of elevated ocular pressure in man [abstract]. Invest Ophthalmol Vis Sci 1992;33:1246.
18. Serle JB, Podos SM, Lippa EA, Kootzbuecher CM. Compassionate case usage of dorzolamide (MK-507) in 16 glaucoma patients [abstract]. Invest Ophthalmol Vis Sci 1994;35:2177.
19. Kitazawa Y, Azuma I, Araie M, Shirato S. Topical dorzolamide hydrochloride can be a substitute for oral carbonic anhydrase inhipbitors [abstract]. Invest Ophthalmol Vis Sci 1994;35:2177.
20. MK-507 Clinical Study Group. Long-term glaucoma treatment with MK-507, dorzolamide, a topical carbonic anhydrase inhibitor. J Glaucoma 1995;4:6-10.
21. Lippa EA, Carlson L-E, Ehinger B, Eriksson L-O, Finnström K, Holmin C. Dose response and duration of action of dorzolamide, a topical carbonic anhydrase inhibitor. Arch Ophthalmol 1992;110:495-9.